A Service of the National Library of Medicine and the National Institutes of Health
RESEARCH ON HEMOCHROMATOSIS and OXIDATIVE STRESS AT PUBMED
Elevated hepatic iron activates NF-E2-related factor 2-regulated pathway in a dietary iron overload mouse model.
Source: Dept of Microbiology and Immunology, Milton S Hershey Medical Center, The Penn State College of Medicine,
Hershey, Pennsylvania 17033, USA.
Abstract: Hepatic iron overload has been associated classically with the genetic disorder hereditary hemochromatosis. More recently, it has become apparent that mild-to-moderate degrees of elevated hepatic iron stores observed in other liver diseases also have clinical relevance. The goal was to use a mouse model of dietary hepatic iron overload and isobaric tag for relative and absolute quantitation proteomics to identify, at a global level, differentially expressed proteins in livers from mice fed a control or 3,5,5-trimethyl-hexanoyl-ferrocene (TMHF) supplemented diet for 4 weeks. The expression of 74 proteins was altered by ≥ ±1.5-fold, showing that the effects of iron on the liver proteome were extensive. The top canonical pathway altered by TMHF treatment was the NF-E2-related factor 2 (NRF2-)-mediated oxidative stress response. Because of the longstanding association of elevated hepatic iron with oxidative stress, the remainder of the study was focused on NRF2. TMHF treatment upregulated 25 phase I/II and antioxidant proteins previously categorized as NRF2 target gene products. Immunoblot analyses showed that TMHF treatment increased the levels of glutathione S-transferase (GST) M1, GSTM4, glutamate-cysteine ligase (GCL) catalytic subunit, GCL modifier subunit, glutathione synthetase, glutathione reductase, heme oxygenase 1, epoxide hydrolase 1, and NAD(P)H dehydrogenase quinone 1. Immunofluorescence, carried out to determine the cellular localization of NRF2, showed that NRF2 was detected in the nucleus of hepatocytes from TMHF-treated mice and not from control mice. We conclude that elevated hepatic iron in a mouse model activates NRF2, a key regulator of the cellular response to oxidative stress. http://www.ncbi.nlm.nih.gov/pubmed/22649188
2005 Study Results: Protandim, the NRF2 Activator, Reducing Oxidative Stress
Consider PROTANDIM®, The Nrf2 Activator!
A fundamental new approach to antioxidant therapy!
Protandim is the ONLY product that has been scientifically proven to reduce oxidative stress by 40% in 30 days.
Watch ABC Primetime Investigative Report on Protandim www.ABCreport.net
Disclaimer: PROTANDIM DOES NOT CLAIM TO TREAT, MITIGATE, DIAGNOSE, CURE, OR PREVENT ANY DISEASE.